|

duloxetine Clinical Trials

8 actively recruiting trials across 3 locations

Also known as: Chemotherapy containing taxanes, Cymbalta, Irenka, duloxetine hydrochloride

Pipeline

Phase 2: 3Phase 4: 4Phase 1/2: 1

Top Sponsors

  • University of Cincinnati2
  • Yan Yang, MD, Ph.D1
  • Sunnybrook Health Sciences Centre1
  • Northwestern University1
  • M.D. Anderson Cancer Center1

Indications

  • Depression3
  • Cancer3
  • Knee Osteoarthritis2
  • Arthritis2
  • Anxiety2

Other4 trials

ADC-induced Neurotoxicity Treated With Duloxetine
Phase 2
Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE)
Phase 4
Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy
Phase 2
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Phase 1/2

Cincinnati, Ohio2 trials

Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)

University of Cincinnati

Phase 4
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)

University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience

Phase 4

Chicago, Illinois1 trial

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis

Northwestern University

Phase 4

Houston, Texas1 trial

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Harris Health System (LBJ)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.